Hikma Pharmaceuticals (HKMPF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Hikma Pharmaceuticals

PNK: HKMPF · Real-Time Price · USD
26.93
0.73 (2.80%)
At close: May 07, 2025, 12:33 PM

Hikma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
133M 226M 59M 131M 15M 173M 173M 248M
Depreciation & Amortization
97.89M 102M 48M 142M 90M 95M 137M 32M
Stock-Based Compensation
12M 15M 15M 10M 12M 10M 13M 16M
Other Working Capital
70M -27M 117M 14M -8M -41M 53M 33M
Other Non-Cash Items
113.11M 78M 125M 86M 265M 17M 114M -53M
Deferred Income Tax
n/a n/a n/a n/a 1M 75M 63M 36M
Change in Working Capital
10M -223M 139M -147M -21M -126M -23M -19M
Operating Cash Flow
366M 198M 386M 222M 361M 169M 414M 224M
Capital Expenditures
-96M -69M -85M -84M -75M -63M -80M -65M
Cash Acquisitions
-150M n/a -88M -10M n/a -373M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-29M -37M -41M -25M -26M -70M -54M -39M
Investing Cash Flow
-275M -106M -214M -119M -101M -506M -134M -104M
Debt Repayment
n/a 47M n/a -14M n/a 692M n/a -25M
Common Stock Repurchased
n/a n/a n/a n/a n/a -300M n/a n/a
Dividend Paid
-71M -104M -55M -82M -42M -83M -42M -78M
Other Financial Acitivies
-65M 5M -184M -2M -307M -18M -133M -9M
Financial Cash Flow
-136M -52M -239M -98M -349M 291M -175M -112M
Net Cash Flow
-236M 236M -67M 2M -101M -55M 104M -1M
Free Cash Flow
270M 129M 301M 138M 286M 106M 334M 159M